Source: Graefe's Archive for Clinical and Experimental Ophthalmology. Unidade: FMRP
Subjects: CATARATA, RETINA, ESTUDOS RETROSPECTIVOS, ACUIDADE VISUAL
ABNT
VIANA, Karlos Ítalo Souza et al. Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH. Graefe's Archive for Clinical and Experimental Ophthalmology, v. 259, n. 1, p. 29-36, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00417-020-04731-7. Acesso em: 21 ago. 2024.APA
Viana, K. Í. S., Gordilho, C. T., Almeida, F. P. P., Esperandio, M. M., Lucena, D. da R., Garcia, D. M., et al. (2021). Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH. Graefe's Archive for Clinical and Experimental Ophthalmology, 259( 1), 29-36. doi:10.1007/s00417-020-04731-7NLM
Viana KÍS, Gordilho CT, Almeida FPP, Esperandio MM, Lucena D da R, Garcia DM, Scott IU, Messias AMV, Jorge R. Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2021 ; 259( 1): 29-36.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1007/s00417-020-04731-7Vancouver
Viana KÍS, Gordilho CT, Almeida FPP, Esperandio MM, Lucena D da R, Garcia DM, Scott IU, Messias AMV, Jorge R. Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2021 ; 259( 1): 29-36.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1007/s00417-020-04731-7